1Abbasciano V;Sartori S;Trevisani L.Neuron-spcific enolase,thymidine kinase,and tissue polypeptide-specific antigen in diagnosis and response to chemotherapy of small-cell lung cancer[J],1999(4).
2Boher JM;Pujol JL;Grenier J.Markov model and markers of small cell lung cancer:assessing the influence of reversible serum NSE,CYFRA21-1 and TPS levels on prognosis,1999(79).
3Stieber P;Dienemann H;Hasholzner U.Comparison of cytokeratin fragment 19 (CYFRA 21-1),tissue polypeptide antigen (TPA) and tissue polypeptide specific antigen (TPS) as tumour markers in lung cancer,1993(31).
4Lein M;Jung K;Hammerer P.A multicenter clinical trial on the use of alphal-antichymotrypsin-prostate-specific antigen in prostate cancer diagnosis,2001.
5Teresa CP;Isabel TZ;Juan BL.Tumor markers in lung cancer:does the method of obtaining the cut-off point and reference population influence diagnostic yield?[J],1999.
6Villena V;Echave-Sustaca J;Lopez-Encuentra A.Determination of tissue polypeptide-specific antigen in pleural fluid and serum from patients with pleural effusion,1995.
7Glovanella L;cerlanl L;Bandera M.Evaluation of the serum markers CEA,TPS and CYFRA 21.1 in lung cancer,1995.
8Pujol JL;Grenier J;Parrat E.Cytokeratins as serum markers in lung cancer:a comparison of CYFRA 21.1 and TPS[J],1996(154).
9Nisman B;Lafair J;Heching N.Evaluation of tissue polypeptide specific antigen,CYFRA 21.1,and carcinoembryonic antigen in nonsmall cell lung carcinoma:does the combined use of cytokeratin Markers give any additional information?[J],1998(10).
10Van der GA;Schoenmakers CH;Kok TC.Prognostic significance of tissue polypeptide-specific antigen (TPS) in pastients with advanced non-small cell lung canceer,1994(30).
3Teresa C P, Isabel T Z, Juan B L, et al. Tumour markers in lung cancer: does the method of obtaining the cut - off point and reference population influence diagnostic yield? [ J ]. Clinical Biochemistry, 1999, 32:467 - 472.
4Ho Y J, Hsieh J F, Tasi S C, et al. Tissue polypeptide specific antigen and squamous cell carcinoma antigen for early prediction of recurrence in lung squamous cell carcinoma[J] .Lung, 2000, 178:75 - 80.
5Bates J, Rutherford M, Divilly M, et al. Clinical value of CYFRA21- 1, carcinoembryonic antigen and tissue polypeptideantigen in the diagnosis of lung cancer[J ]. Eur Respir J, 1997,10:2535 - 3538.
6Manual D, Antonio T, Marina P, et al. Prognostic significance of serum CA125 antigen assay in patients with non - small cell lung cancer[J ]. Cancer, 1994, 73:1368 - 1376.
7Ho YJ,Hsieh JF,Tasi SC,et al.Tissue polypeptide specific antigen and squamous cell carcinoma antigen for early predicaion of recurrence in lung sqnamous[J].Lung,2000,178(2):75-80.
8Padungsutt P,Thirapaowong C,Senapad S,et al.Accuracy of serum tissue polypeptide specific antigen (TPS) in the diagnosis of ovarian malignancy[J].Anticancer Res,2000,20(2B):1291-1305.
9Bjorklund B,Einarsson R.TPS (serum tissue polypeptide specific antigen) in oncologic practice:a Review with reference to 3000 cases oflungcancer[J].TumorDiagnosisandTherapy,1996,17(1):67-71.
10Einarsson R,Rydlander L.Tissue polypeptide specific antigen (TPS) detects a specific epitope structure on human cytokeratin[J].Anticancer Res,1997,17 (4B):3121-3124.
